The Utah Governor’s Office of Economic Opportunity has renamed its Salesforce grant application and customer service portals as part of its rebranding. The office no longer goes by GOED, but by Go Utah, or the Economic Opportunity office.
The Utah Governor’s Office of Economic Opportunity (Go Utah) and the Economic Development Corporation of Utah (EDCUtah) are pleased to announce that Cytiva will expand its facility in Logan, Utah, adding up to 396 new high-paying Utah jobs in the next 10 years. Capital expenditures associated with the project are $231 million.
Newly released data from the University of Utah’s Kem C. Gardner Policy Institute shows that Utah’s mature life sciences industry – our BioHive – continues to experience strong growth relative to state and national trends, even during the pandemic.
Last month, The Point of the Mountain released its latest Framework Plan.
Dan Lundergan, MHA, COO at University of Utah Health Hospitals and Clinics, has been appointed to the role of CEO. He has served as interim CEO since February and steps into the official role beginning immediately.
BlueWind Medical has announced that the 100th patient has been enrolled in its OASIS (Overactive bladder stimulation system) study—a clinical pivotal trial designed to test the safety and efficacy of the Renova iStim system in providing tibial neuromodulation (TNM) therapy.
Last month, BioUtah News and Events reported that the U.S. Ski and Snowboard Team would be using R-Zero’s hospital-grade, whole-room ultraviolet light disinfection system called Arc to mitigate against COVID-19 and other pathogens in their training rooms.
Peer-reviewed results describe the Company’s test being used to confirm the presence of the virus on community waste, including mutated strains
On Monday, U.S. Rep. Burgess Owens (R-UT-4) spent the day visiting a number of life sciences companies – Owlet, Spectrum Solutions, Merit Medical, Matia Robotics and ARUP Laboratories.
Ron Heffernan, Managing Partner at Mountain Pacific Partners recently announced the launch of Mountain Pacific’s newest funds.
World-renowned neurologist and movement disorders specialist joins PhotoPharmics as company advances breakthrough device through pivotal clinical trial and to commercialization.
Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic.